Printed from https://fiscalreceipts.com/program/0604807A/ — built September 26, 2026. Every figure is citation-backed; see the page online for per-number provenance.
Medical Materiel/Medical Biological Defense Equipment - Eng Dev
Budget figures
FY2026 award data is a partial year — USAspending reports awards on a rolling basis, and this corpus runs through 2026-09-04. why partial FY2026 data? →
Budget trajectory
| Fiscal year | Amount |
|---|---|
| FY24 | $11.0M |
| FY25 | $7.14M |
| FY26 | $6.25M |
All series figures: R-1 TOA · PB2026
Decade view
P-1/R-1 workbook TOA basis, shown compact in $B/$M (the workbook records USD thousands); each figure cites its own President's Budget edition
The vertical scale does not start at zero: the baseline sits just below this program’s smallest year, so a low point on this line is not a small amount. Read the shape for direction and the grid below for the figures.
● actuals (line) · ○ enacted · ◇ request — gaps are editions the program is absent from, never interpolated.
| Series | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actuals | $29.4M | $39.3M | $36.2M | $36.7M | $45.1M | $70.5M | $48.3M | $43.0M | $25.0M | $11.0M | ||
| Enacted | $45.4M | $41.1M | $39.2M | $44.5M | $48.3M | $51.3M | $44.4M | $5.51M | $6.50M | $7.14M | ||
| Request | $41.1M | $39.2M | $44.5M | $48.3M | $49.9M | $44.4M | $5.51M | $6.50M | $7.14M | $6.25M |
blank = series not published for this year; – = absent from that edition.
Asked vs spent: the PB2020 book requested $48.3M for FY2020; the PB2022 book reported $70.5M as actual total obligation authority — $22.2M above the request. 70.5 − 48.3 = 22.2 USD millions — the compact figures above are rounded for reading.
Program lineage
No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.
Description
Mission — Medical Materiel/Medical Biological Defense Equipment - Eng Dev
This Program Element (PE) funds advanced development of medical materiel within the System Demonstration and Low Rate Initial Production portions of the acquisition life cycle using Budget Activity 6.5 (System Development and Demonstration) funding. It supports products successfully developed in the Systems Integration portion of the Systems Development and Demonstration phases through completion of the Milestone C Decision Review. Commercially-off-the-shelf (COTS) medical products are also tested and evaluated for military use, when available. This PE primarily includes pivotal (conclusive) human clinical trials necessary for licensure by the Food and Drug Administration (FDA). Projects in this PE include the following: Project 832 funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. Mature COTS medical products are also evaluated for military use. Consideration will also be given to reduce the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. Products from this project will normally transition to OPA Funds. The FY 2026 request was reduced by $0.344 million for Advisory and Assistance Services to promote efficiencies and advance the policies of the Administration in alignment with Executive Order 14222, "Implementing the President's Department of Government Efficiency Cost Efficiency Initiative." The FY 2026 request was reduced by $0.049 million for civilian personnel to optimize the workforce in compliance with Executive Order 14210, "Implementing the President's Department of Government Efficiency Workforce Optimization Initiative."
Mission — Field Medical Systems Engineering Development
This Project funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care. Commercially available medical products are also evaluated for military use. This project funds pivotal (conclusive) human clinical trials or mechanical engineering evaluations for effectiveness of devices or biologics (products derived from living organisms) to fulfill unique military requirements. Project Managers also consider reductions to the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. This work is frequently completed through a laboratory/contractor team with the contractor obtaining the U.S. Food and Drug Administration (FDA) licensure for sale of the product.
Justification
Accomplishments & Planned Programs (1)
Field Medical Systems Engineering Development - Medical Readiness
Funding is provided for engineering and manufacturing development of medical products for diagnostic devices and testing of medical devices for use in the field.
Budget line items(workbook-cited)
P-1/R-1 workbook Total Obligation Authority basis (USD thousands) · PB2026.
Exhibit R-1
| Account | Org | Type | Amount |
|---|---|---|---|
| Research, Development, Test and Evaluation, Army | A | FY24 Actuals | $11.0M |
| Research, Development, Test and Evaluation, Army | A | FY25 Enacted | $7.14M |
| Research, Development, Test and Evaluation, Army | A | FY25 Total | $7.14M |
| Research, Development, Test and Evaluation, Army | A | FY26 Disc. Request | $6.25M |
| Research, Development, Test and Evaluation, Army | A | FY26 Total | $6.25M |
Budget Details(R-2/P-40 facts)
J-book detail basis (R-2/P-40, USD millions) · PB2026 — a different accounting basis from the P-1/R-1 workbook TOA above; where the two disagree, the reconciliation strip under Budget figures shows both.
Wider than this screen — swipe the table sideways for the remaining fiscal-year columns.
| Project | FY24 Actuals | FY25 Total | FY26 Base | FY26 Request |
|---|---|---|---|---|
| Program Element | $11.0M | $7.14M | $6.25M | $6.25M |
| 832: Field Medical Systems Engineering Development | $11.0M | $7.14M | $6.25M | $6.25M |
Follow the dollar
No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 312 of 1,938 programs). why coverage is partial? →
Awards
No awards are linked to this program element at high or medium confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.
Lobbying mentions
No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.
Oversight
Department-level designation (not specific to this program)
GAO lists 5 high-risk areas for DOD as a whole. That designation covers the department, not Medical Materiel/Medical Biological Defense Equipment - Eng Dev. No program-specific GAO finding for this line is in the ingested data. See the DOD oversight record.
Program dossier
No research dossier for this program — dossiers cover 50 of 1,938 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →
Primary sources
Open any budget figure for its exact receipt. Verified line items lead with the highlighted government PDF; original spreadsheets download with their budget edition and exhibit in the filename.
Budget totals · TOA sources
FY2026 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J122
Complete workbook · unchanged saved copy. Saves as PB2026_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2017 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J102
Complete workbook · unchanged saved copy. Saves as PB2017_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2018 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J109
Complete workbook · unchanged saved copy. Saves as PB2018_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2019 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J112
Complete workbook · unchanged saved copy. Saves as PB2019_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2020 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J135
Complete workbook · unchanged saved copy. Saves as PB2020_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2021 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J143
Complete workbook · unchanged saved copy. Saves as PB2021_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2022 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J113
Complete workbook · unchanged saved copy. Saves as PB2022_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2023 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J115
Complete workbook · unchanged saved copy. Saves as PB2023_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2024 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J114
Complete workbook · unchanged saved copy. Saves as PB2024_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
FY2025 Department of Defense Budget: RDT&E Programs (R-1) · comptroller.war.gov
Exhibit R-1 · J113
Complete workbook · unchanged saved copy. Saves as PB2025_DoD_R-1_Research-Development-Test-Evaluation.xlsx.
Detailed budget justification
The related TOA spreadsheets above use a different accounting basis from R-2/P-40 detail. Their amounts are not assumed to match these detailed sources.
RDTE - Vol 3 - Budget Activity 5A · www.asafm.army.mil